Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | P2RY2 | P41231 | 12/20 | 0.94 |
| ▸ | P2RY4 | P51582 | 7/20 | 0.94 |
| ▸ | P2RY6 | Q15077 | 6/20 | 0.94 |
| ▸ | P2RY14 | Q15391 | 7/20 | 0.85 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Uridine Triphosphate SCHEMBL12636116 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL2778525 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| SCHEMBL376210 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL76683 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL14976686 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL24414746 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL107380 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL14406726 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL12671699 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 | |
| Uridine Triphosphate SCHEMBL29829840 | 1.00 | P2RY2 (0.94) | P2RY2P2RY4P2RY6P2RY14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 19208 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260146271-A1 | UDP-SUGAR BIOPRODUCTION USING MICROORGANISM HOSTS | Debut Biotechnology, Inc. (US) | 2026-05-28 | — | — | US | claimed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-3620510-B2 | FERMENTATIVE PRODUCTION OF OLIGOSACCHARIDES BY TOTAL FERMENTATION UTILIZING A MIXED FEEDSTOCK | CHR HANSEN HMO GMBH (DE) | 2026-05-27 | — | — | EP | claimed |
| CN-122095100-A | Method for designing broad RNA modification library containing all surrounding sequences of RNA modification and use thereof | — | 2026-05-26 | — | — | CN | claimed |
| CN-122075713-A | Deaminase and use of transaminase in the treatment of polyglutamine diseases | — | 2026-05-26 | — | — | CN | claimed |
| CN-120733020-B | H3N2 influenza mRNA vaccine with HA and NA proteins in series as targets and preparation method thereof | INSTITUTE OF MEDICAL BIOLOGY CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2026-05-26 | — | — | CN | claimed |
| US-12640285-B2 | Highly flame-retardant UTP cable | LS CABLE & SYSTEM LTD. (KR) | 2026-05-26 | — | — | US | claimed |
| WO-2026103936-A1 | CHEMICALLY MODIFIED CIRCULAR RNA MOLECULE, PREPARATION METHOD THEREFOR, AND USE THEREOF | 上海元码智药生物技术有限公司 | 2026-05-21 | — | — | WO | claimed |
| WO-2026106952-A1 | METHODS FOR TREATING CONGENITAL DISORDERS OF GLYCOSYLATION | CDG CARE (US) | 2026-05-21 | — | — | WO | claimed |
| CN-122060717-A | Method for prolonging drug effect of mRNA (messenger ribonucleic acid) drug, product and application | 中国科学技术大学 | 2026-05-19 | — | — | CN | claimed |
| US-5292498-A | Method of treating lung disease with uridine triphosphates | THE UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL (US) | 1994-03-08 | — | — | US | claimed |
| EP-0553821-A1 | Process for producing cytidine diphosphate choline | KYOWA HAKKO KOGYO CO., LTD. (JP) | 1993-08-04 | — | — | EP | claimed |
| EP-0519053-A4 | NUCLEIC ACID AMPLIFICATION WITH DNA-DEPENDENT RNA POLYMERASE ACTIVITY OF RNA REPLICASES | — | 1993-03-31 | — | — | EP | claimed |
| EP-0519053-A1 | NUCLEIC ACID AMPLIFICATION WITH DNA-DEPENDENT RNA POLYMERASE ACTIVITY OF RNA REPLICASES. | PROMEGA CORP (US) | 1992-12-23 | — | — | EP | claimed |
| EP-0517573-A1 | Pharmaceutical compositions for the treatment of airway disorders | SYNTHELABO (FR) | 1992-12-09 | — | — | EP | claimed |
| WO-1992012261-A1 | NUCLEIC ACID AMPLIFICATION WITH DNA-DEPENDENT RNA POLYMERASE ACTIVITY OF RNA REPLICASES | PROMEGA CORPORATION (US) | 1992-07-23 | — | — | WO | claimed |
| US-4959212-A | ENZYMES AND COENZYMES | STANCESCO ALEXANDRA (US) | 1990-09-25 | — | — | US | claimed |
| EP-0076647-A2 | Culture media for cells originating from the immune system | HANA Biologics Incorporated (US) | 1983-04-13 | — | — | EP | claimed |
| EP-0009076-B1 | METHOD FOR THE QUANTITATIVE ENZYMATIC DETERMINATION OF ADP AND REAGENT FOR THIS METHOD | Roche Diagnostics GmbH (DE) | 1981-07-29 | — | — | EP | claimed |
| EP-0009076-A1 | Method for the quantitative enzymatic determination of ADP and reagent for this method | Roche Diagnostics GmbH (DE) | 1980-04-02 | — | — | EP | claimed |